Home > Journals > Medicine > European Journal of Dermatology > Full text
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
European Journal of Dermatology
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
  Printable version

Perifolliculitis capitis abscedens et suffodiens successfully controlled with topical isotretinoin


European Journal of Dermatology. Volume 13, Number 2, 192-5, March - April 2003, Cas cliniques


Summary  

Author(s) : Anthony KARPOUZIS, Alexandra GIATROMANOLAKI, Efthymios SIVRIDIS, Constantin KOUSKOUKIS, Department of Dermatology, School of Medicine, Democritus' University of Thrace, University Hospital of Alexandroupolis, 92 Karaoli and Dimitriou street, 68100, Alexandroupolis, Greece.

Summary : Perifolliculitis capitis abscedens et suffodiens (or dissecting folliculitis of the scalp or dissecting cellulitis of the scalp or dissecting perifolliculitis of the scalp) is a rare entity and constitutes the equivalent over the scalp, of hidradenitis suppurativa and acne conglobata. Etiologic factors are unknown. Diagnosis is proven histologically. Management is very difficult and consists in systemic administration or intralesional injection of several drugs or in surgical manipulations. An 18 year-old white patient with cystic infiltrations, alopecia plaques, pustules and other inflammatory elements (clinicohistological features consistent with dissecting folliculitis of the scalp), is presented. Isotretinoin topical application assured successful control of the disease and averted the evolution of the clinical aspect to scarring alopecia and nodule formation. Topical isotretinoin exercises a curative, inhibitory and antiproliferative action, in perifolliculitis capitis abscedens et suffodiens.

Keywords : Perifolliculitis capitis abscedens et suffodiens, dissecting folliculitis of the scalp, dissecting cellulitis of the scalp, dissecting perifolliculitis of the scalp, topical isotretinoin.

Pictures

ARTICLE

Perifolliculitis capitis abscedens et suffodiens (otherwise known as dissecting folliculitis of the scalp or as dissecting cellulitis of the scalp or also as Hoffman's disease) is an uncommon, chronic, progressive, inflammatory, suppurative scalp disorder that almost exclusively affects Afro-Caribbean males. Spitzer in 1903 first described this entity (under the title Dermatitis Follicularis et Perifollicularis Conglobata) in association with severe acne conglobata. The second case report was presented by Nobl, before the Vienna Dermatological Society October 26, 1904, which fits into the clinical description of Hoffman's case. Hoffman presented the next case to the Berlin Dermatological Society on March 12, 1907 and named the disease perifolliculitis capitis abscedens et suffodiens [1]. It is a descriptive denomination (suffodiens: latin suffodio to dig under).


Interest in this clinical case presentation arises from the following data: (a) very few cases of dissecting folliculitis in white patients have been reported in the literature, (b) clinical features of this entity as well as the corresponding (to each case) histological picture may vary from case to case, (c) therapeutic means that have been applied and described in the literature are limited and frequently disappointing, (d) causes are unknown. Familial cases have been reported rarely [2, 3], (e) risk of malignant transformation of Hoffman's disease lesions has already been recognized [4, 5].


Case report


Our patient was a 20 year-old white male subject, presented at consultation because he sensed six months ago (and he has since observed) the existence (on the vertex region of the scalp) of two circumscribed, oval (of 3 cm in maximal diameter) alopecia plaques, in the central area of which a monofocal growth hair was left. Very small pustules were observed on the erythematous and inflammatory surface of these plaques. These alopecia areas are neighboring and a thin zone of normally growing hair was interposed between them (Fig. 1). We ascertained by palpation that very infiltrated and relatively yielding cystic formations, existed under the baldness plaques. A similar cystic formation, reminiscent of a sebaceous cyst, was palpated in the left-lateral area of the nape. The patient had mild microcystic and pustular acne on the face and the back. Before admission at our consultation, the patient had been managed by trials including systemic administration of antibiotics or corticosteroids as well as subcutaneous injection of corticosteroids. The above treatments had assured mild regression for 20 to 30 days and afterwards, a relapse (much more inflammatory compared to the preexisting clinical aspect) occurred.

We ordered repeated bacteriologic, mycologic, mycobacteriologic and virologic investigations from the scalp lesions (showing no pathological findings). The exhaustive haematological-biochemical-immunological investigations as well as the computed tomography of visceral cranium and brain, were normal. Two biopsies (one on each plaque) have been realized and the relevant histological studies showed similar findings between them. The development of inflammatory, granulomatous tissue (with abundance of epithelioid histiocytes and polynuclear giant cells as of Langerhans' type as of foreign body type) was observed in the dermis (Figs. 2, 3). Special stains for bacteria, mycobacteria and fungi were negative. The diagnosis of dissecting cellulitis of the scalp was verified. A clindamycin gel (1 %) and an isotretinoin gel (0.05 %) were applied topically on the totality of the alopecia plaques and after a treatment of two months, the pustules and the other inflammatory elements disappeared, the cystic infiltration was reduced dramatically and a diffuse hair growth was observed on half at least, of the surface of the plaques (Fig. 4). We proposed an isotretinoin systemic administration in order to ensure a more rapid and impressive therapeutic result but our patient refused this treatment. Isotretinoin topical application for further eight months, maintaining the obtained result, was followed by an one year period without treatment and without relapse.


Discussion


We presented above an 18 year-old male patient of phototype IV. Only 3 patients (among almost 50 cases analytically published in the literature) [1-23] concern subjects of the white race [10, 16, 21] (in 4 cases the race of the patients was not elucidated [9, 15, 16, 18] whereas all the other presentations included black patients). The majority of the patients are male (except 7 female subjects) [7, 11, 14, 15, 19]. First appearance of the disease age varies from 15 to 33 year-old, except one case concerning a lymphoma presenting as dissecting folliculitis [5]. It is worthwhile to report that the malignant transformation of the disease to squamous cell carcinoma, has been diagnosed at the age of 41 year-old (where dissecting folliculitis appeared 19 years previously) [4]. Clinically the disease begins as a folliculitis, most commonly involving the vertex and/or occipital scalp. This is rapidly followed by horizontal spreading, abscess, sinus formation and alopecia. Our patient presented at consultation in this second clinical evolutionary phase.


The whole process ends up with cicatrization and nodular formation. These nodules suppurate and spread to form intercommunicating sinuses. These sinuses, as long as 4 cm to 5 cm, can be easily traced by a probe. Seropurulent drainage may last indefinitely. The nodular form of five cases was associated with spontaneous severe pain [4, 10, 22, 23]. Sometimes a swelling of beard area may coexist.


The disease starts with a keratinized occluded follicular orifice. Stasis in the pilosebaceous apparatus promotes
fertile soil for bacterial multiplication. Folliculitis and perifoculitis results from follicular occlusion either from immune-immediate chronic inflammation resulting from hypersensitivity to Propionibacterium acnes or an immune complex disorder. Secondary infection probably ensues. Staph. aureus, staph. epidermidis, strept. beta-haemolytic, pseudomonas aeruginosa and diphtheroid bacilli may be isolated [4, 7, 8, 11, 12, 15]. However, bacteriologic cultures are usually negative [13, 18, 20-23].


The younger lesions showed a benign hyperkeratosis around the follicle orifice, atrophy of the orifice, massive keratotic plugging and an infiltrate (in the upper dermis) consisting primarily of neutrophils. Lesions of longer duration had an infiltrate of plasma cells, histiocytes, lymphocytes in the upper and middle corium. Older lesions showed predominantly plasma cells [11, 12, 15, 23]. A foreign body giant cell reaction and granulomatous tissue formation are observed in the abscess-alopecia second stage of the disease (as seen in our case) as well as in the nodular-cicatrizant phase. The giant cells frequently had material in them, which appeared to be keratin. There were changes of liquefaction degeneration of the collagen and elastic tissue around the areas of inflammation [4, 6, 7, 9, 14, 15, 21]. Combination with acne vulgaris is common (in 30 % of the cases). The disease is considered to be part of the follicular occlusion tetrad, together with acne conglobata, chronic hidradenitis suppurativa and pilonidal cysts [8, 24]. The central pathogenic event in all four entities is a tendency toward follicular hyperkeratosis leading to retention of follicular products with secondary bacterial infection. The common anatomoclinical features of the follicular occlusion are the following: formation of multiple comedones, abscesses with communicating channels, discharging sinuses.


Squamous cell carcinomas may arise within acne conglobata and hidradenitis suppurativa. One case in which a metastasizing squamous cell carcinoma developed in a long-standing lesion, has already been reported [4]. An aggressive large cell variant of folliculotropic mycosis fongoïdes should be included in the differential diagnosis of dissecting cellulitis of the scalp, emphasizing the importance of a biopsy in any nonhealing lesion, to rule out lymphoma [5]. Cutaneous signs of follicular occlusion may coexist with asymmetric peripheral and axial arthritis [7, 21, 22].


Treatment is varied and generally unsuccessful. Oral antibiotics and oral zinc have occasionally produced good results [16]. Satisfactory results using x-ray epilation have been reported but radiation therapy for benign conditions is avoided because of potential long-term adverse effects [14]. Systemic or intralesional steroids provide only partial relief, moreover might favor eventual malignant transformation [15, 20]. Oral isotretinoin is effective, although it needs to be continued for 4 months after clinical control is achieved, to prevent relapse [2, 16, 17, 22, 23]. Oral isotretinoin has been proven sufficiently efficacious as monotherapy [23], in the abscess-alopecia second stage whereas oral antibiotics and/or systemic (or intralesional) steroids have been required (as combination therapy with POs retinoids) in the nodular-scarring third stage of the disease [22]. A surgical approach may be employed in resistant nodular cases. The lesions are incised and drained. It is possible to pass a probe through burrows of interconnecting pustular nodules. Intercommunicating sinuses should be marsupialized and the surface is cauterized to destroy the epithelium lining the sinuses [18]. Removal of the entire scalp with subsequent grafting has been published [12].

CONCLUSION

In our case the topical isotretinoin and clindamycin blocked the disease in its second phase and thus inhibited the evolution to scarring and nodular stage. Clindamycin has antibacterial and antiinflammatory action [25]. Topical isotretinoin (as well as the topical retinoic acid or the adapalene) is characterized by antiinflammatory activity as well as desquamative and keratolytic action at the follicle infundibulum. Hair regrowth was eventually favored by the inhibitory retinoid action concerning the enzymatic 5a-reductase activity [26, 27]. Therefore as already supposed in hidradenitis suppurativa [28, 29], hormonal etiopathogenetic mechanisms are suspected in dissecting folliculitis and have to be looked for in the future. Moreover continuous isotretinoin topical application might protect from eventual malignant transformation [30].

Article accepted on 23/12/2002

REFERENCES

1 - Hoffman E. Perifolliculitis capitis abscedens et suffodiens: Case Presentation. Dermat Ztschr 1908; 16: 122-3.


2 - Bjellerup M, Wallengren J. Familial perifolliculitis capitis abscedens et suffodiens in two brothers successfully treated with isotretinoin. J Am Acad Dermatol 1990; 23: 752-3.


3 - Ramesh V. Dissecting cellulitis of the scalp in 2 girls. Dermatologica 1990; 180: 48-50.


4 - Curry SS, Gaither DH, King LE. Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. J Am Acad Dermatol 1981; 4: 673-8.


5 - Gilliam AC, Lessin SR, Wilson DM, Salhany KE. Folliculotropic mycosis fungoides with large-cell transformation presenting as dissecting cellulitis of the scalp. J Cutan Pathol 1997; 24: 169-75.


6 - Cannon AB. Perifolliculitis capitis abscedens et suffodiens: Case Presentation. Arch Dermat Syph 1944; 49: 67-8.


7 - Wasserman E. Perifolliculitis Capitis Abscedens et Suffodiens with Pheumatoid Athritis. AMA Arch Dermat Syph 1951; 64: 787-9.


8 - Kierland RR. Unusual pyodermas (hidrosadenitis suppurativa, acne conglobata, dissecting cellulitis of the scalp). A review. Minn Med 1951; 34: 319-41.


9 - Reynaers H. Folliculites et Perifolliculites abcedantes de Hoffmann (AcnE Conglobata du Cuir Chevelu). Arch Belg Dermatol 1954; 10: 42-4.


10 - Gasner WG. Perifolliculitis Capitis Abscedens et Suffodiens:Report of a Case and Response to Therapy. New York J Med 1957; 57: 947-8.


11 - Moyer DG, Williams RM. Perifolliculitis capitis abscedens et suffodiens. A Report of six Cases. Arch Dermatol 1962; 85: 118-24.


12 - Moschella SL, Klein MH, Miller RJ. Perifolliculitis Capitis Abscedens et Suffodiens. Report of a successful therapeutic scalping. Arch Dermatol 1967; 96: 195-7.


13 - Kumar PP, Henschke UK, Kovi J. Perifolliculitis capitis abscedens et suffodiens. JAMA 1976; 68 (1): 9-13.


14 - Adrian RM, Arndt KA. Perifolliculitis capitis: Successful Control with Alternate-Day Corticosteroids. Ann Plast Surg 1980; 4 (2): 166-9.


15 - Berne B, Venge P, Ohman S. Perifolliculitis capitis abscedens et suffodiens (Hoffman). Arch Dermatol 1985; 121: 1028-30.


16 - Schewach-Millet M, Ziv R, Shapira D. Perifolliculitis capitis abscedens et suffodiens treated with isotretinoin. J Am Acad Dermatol 1986; 6: 1291-2.


17 - Taylor AEM. Dissecting cellulitis of the scalp: Response to isotretinoin. Lancet 1987; 25: 225.


18 - Glass IF, Berman B, Laud D. Treatment of perifolliculitis capitis abscedens et suffodiens with the carbon dioxide laser. J Dermatol Surg Oncol 1989; 15: 673-6.



19 - Benvenuto MF, Rebora A. Fluctuant nodules and alopecia of the scalp. Perifolliculitis capitis abscedens et suffodiens. Arch Dermatol 1992; 128: 1118-9.


20 - Shaffer N, Billick RC, Srolovitz H. Perifolliculitis capitis abscedens et suffodiens. Resolution with combination therapy. Arch Dermatol 1992; 12: 1329-31.


21 - Olafsson S, Khan MA. Musculoskeletal features of acne, hidradenitis suppurativa and dissecting cellulitis of the scalp. Rheum Dis Clin North Am 1992; 18: 215-22.


22 - Dyall-Smith D. Signs, syndromes and diagnoses in Dermatology: Dissecting cellulitis of the scalp. Austral J Dermatol 1993; 34: 81-2.


23 - Scerri L, Williams HC, Allen BR. Dissecting cellulitis of the scalp: response to isotretinoin. Br J Dermatol 1996; 134: 1105-8.


24 - Pillsbury DM. Bacterial infections of the skin. In: Pillsbury DM, Shelley WE, Kligman AE, eds. Dermatology, Philadelphia. W.B. Saunders Co; 1956: 481-3.


25 - Eady EA, Jones CE, Vyarkman S, Cove JF, Cunliffe WJ. Increasing prevalence of antibiotic resistant propionibacteria on the skin of acne patients. Results of a five years study. Br J Dermatol 1997; 137 (suppl. 50): 27-8.


26 - Gomez E. Actions of isotretinoin and etretinate on the pilosebaceous unit. J Am Acad Dermatol 1982; 6 (suppl. 4): 746-50.


27 - Leyden JJ, McGinley K. Effects of 13-cis-retinoic acid on sebum production and Propionibacterium acnes in severe nodulocystic acne. Arch Dermatol Res 1982; 272: 331-7.


28 - Ebling FJG. Hidradenitis suppurativa:an androgen-dependent disorder. Br J Dermatol 1986; 115: 259-62.


29 - Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptive. Br Med J 1989; 298: 28-9.


30 - Frey JR, Peck R, Bollag W. Antiproliferative activity of retinoids, interferon alpha and their combination in five human transformed cell lines. Cancer Lett 1991; 57: 223-7.


 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]